GBD 2021 Stroke Risk Factor Collaborators (2024) Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(10):973–1003. https://doi.org/10.1016/S1474-4422(24)00369-7

Article  Google Scholar 

Dawson J, Béjot Y, Christensen LM et al (2022) European stroke organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. Eur Stroke J 7(3):I. https://doi.org/10.1177/23969873221100032

Article  PubMed  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 44(38):3720–3826. https://doi.org/10.1093/eurheartj/ehad191

Article  CAS  PubMed  Google Scholar 

Antithrombotic Trialists' (ATT) Collaboration, Baigent C et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678):1849-60. https://doi.org/10.1016/S0140-6736(09)60503-1

Bhatt DL, Scheiman J, Abraham NS et al (2008) ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 118(18):1894–909. https://doi.org/10.1161/CIRCULATIONAHA.108.191087

Article  PubMed  Google Scholar 

Eikelboom JW, Hirsh J, Spencer FA et al (2012) Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e89S-e119S. https://doi.org/10.1378/chest.11-2293

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galli M, Occhipinti G, Angiolillo DJ (2024) Aspirin hypersensitivity and intolerance. Eur Heart J Cardiovasc Pharmacother 10(3):173–174. https://doi.org/10.1093/ehjcvp/pvae008

Article  CAS  PubMed  Google Scholar 

Wang Y, Zhao X, Lin J et al (2016) Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316(1):70–8. https://doi.org/10.1001/jama.2016.8662

Article  CAS  PubMed  Google Scholar 

Cardiovascular Physicians Branch of Chinese Medical Doctor Association, Chinese Stroke Association, China Chapter of International Union of Angiology (2021) Expert consensus on diagnosis and treatment of patients with intolerance and low responsiveness to commonly used oral antiplatelet drugs. Chin J Interv Cardiol 29(05):240–9. https://doi.org/10.3969/j.issn.1004-8812.2021.05.001

Article  Google Scholar 

Chinese Society of Cardiology, Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology (2024) Chinese guidelines for the diagnosis and management of patients with chronic coronary syndrome. Chin J Cardiol 52(6):589–614. https://doi.org/10.3760/cma.j.cn112148-20240325-00168

Article  Google Scholar 

Chinese Society of Cardiology of Chinese Medical Association, Metabolic Cardiovascular Disease Group, Editorial Board of Chinese Journal of Cardiology (2021) Chinese expert consensus on comprehensive management of cardiovascular risk in patients with cardiovascular diseases and abnormal glucose metabolism. Chin J Cardiol 49(7):656–72. https://doi.org/10.3760/cma.j.cn112148-20210114-00050

Article  Google Scholar 

Pan Y, Meng X, Yuan B et al (2023) Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial. Lancet Neurol 22(6):485–493. https://doi.org/10.1016/S1474-4422(23)00113-8

Article  CAS  PubMed  Google Scholar 

Wu H, Xu L, Zhao X et al (2023) Indobufen or Aspirin on top of Clopidogrel after coronary drug-eluting stent implantation (OPTION): a randomized, open-label, end point-blinded, noninferiority trial. Circulation 147(3):212–222

Article  CAS  PubMed  Google Scholar 

The Neurology Branch of the Chinese Medical Association, the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association (2024) Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023. Chin J Neurol 57(6):523–559

Google Scholar 

Virani SS, Newby LK, Arnold SV et al (2023) 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology joint committee on clinical practice guidelines. Circulation 148(9):e9–e119

Article  PubMed  Google Scholar 

Jing Y, Hong T, Bi Y et al (2018) Prevalence, treatment patterns and control rates of metabolic syndrome in a Chinese diabetic population: China cardiometabolic registries 3B study. J Diabetes Investig 9(4):789–798

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu S, Xu H, Xu L et al (2025) Indobufen versus Aspirin plus Clopidogrel in patients after coronary stenting in patients with diabetes: a post hoc analysis of the OPTION trial. J Diabetes 17(9):e70152

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Pu S, Jin A et al (2025) Effect of stroke severity on efficacy and safety of Indobufen versus Aspirin in patients with moderate to severe stroke: results from the INSURE randomized clinical trial. J Atheroscler Thromb 32(12):1586–1600

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greco A, Occhipinti G, Giacoppo D et al (2023) Antithrombotic therapy for primary and secondary prevention of ischemic stroke: JACC state-of-the-art review. J Am Coll Cardiol 82(15):1538–1557. https://doi.org/10.1016/j.jacc.2023.07.025.

Article  PubMed  Google Scholar 

Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284(10):1247–1255. https://doi.org/10.1001/jama.284.10.1247

Article  CAS  PubMed  Google Scholar 

Liu J, Sun P, Qi X (2023) Reversible and non-competitive inhibition of cyclooxygenase by indobufen for efficient antiplatelet action and relief of gastrointestinal irritation. Pharmaceutics 15(8):2135. https://doi.org/10.3390/pharmaceutics15082135

Article  CAS  PubMed  PubMed Central  Google Scholar